摘要 |
There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases. |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
BALDWIN, IAN ROBERT;BARKER, MICHAEL DAVID;DEAN, ANTHONY WILLIAM;ELDRED, COLIN DAVID;EVANS, BRIAN;GOUGH, SHARON LISA;GUNTRIP, STEPHEN BARRY;HAMBLIN, JULIE NICOLE;HOLMAN, STUART;JONES, PAUL;LINDVALL, MIKA KRISTIAN;LUNNISS, CHRISTOPHER JAMES;REDFERN, TRACY JANE;REDGRAVE, ALISON JUDITH;ROBINSON, JOHN EDWARD;WOODROW, MICHAEL |